Riskpilot← Back to searchSign inGet full accessBioaktiva Nordic AB
ABActiveOrg 5593443798Lötängsgatan 7Wholesale of other food · NACE 4638Est. 20211 employees
Revenue 2024
SEK 178K
-59% vs 2023
EBITDA margin
3.8%
+103% vs 2023
Equity ratio
88.8%
Financial strength
Net profit 2024
SEK 7K
+103% vs 2023
| Revenue | SEK 178K | -59% |
| EBITDA | SEK 7K | +103% |
| Net profit | SEK 7K | +103% |
| Total assets | SEK 98K | -25% |
| Equity | SEK 87K | +8% |
| Employees | 1 | — |
Legal name
Bioaktiva Nordic AB
Org number
5593443798
Legal form
Aktiebolag
NACE code
4638 · Wholesale of other food
Founded
4 november 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas ensam av externa firmatecknaren Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget ska sälja och marknadsföra egenvårdsprodukter till detaljhandeln, framför allt apotek och hälsokostbutiker.
Address
Lötängsgatan 7
Email
info@bioaktiva.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 125 | 439 | 178 |
| Staff expenses | −85 | −230 | −9 |
| EBITDA | 24 | −217 | 7 |
| Depreciation & amort. | — | — | — |
| EBIT | 24 | −217 | 7 |
| Net financials | — | −0 | 0 |
| Profit before tax | 24 | −217 | 7 |
| Tax | −5 | — | — |
| Net profit | 19 | −217 | 7 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 79 | 131 | 98 |
| Equity | 44 | 80 | 87 |
| Long-term debt | — | — | — |
| Short-term debt | 36 | 51 | 11 |
| Total debt | 36 | 51 | 11 |
EBITDA margin
3.8%
This company
15.8%
Market median
-76% vs market
20222024
Equity ratio
88.8%
This company
38.2%
Market median
+132% vs market
20222024
Return on equity
7.8%
This company
18.4%
Market median
-58% vs market
20222024
Net profit margin
3.8%
This company
8.1%
Market median
-53% vs market
20222024
Asset turnover
1.82×
This company
1.12×
Market median
+62% vs market
20222024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
DL Chief Executive Officer | Chief Executive Officer | 2025 |
PW | Audit | 2025 |
LE External Signatory | External Signatory | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bioaktiva Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Daniel Lars Jern | Chief Executive Officer | 0 companies |
| Pär Wilhelm Konradsson | Audit | 0 companies |
| Lars Eric Jern | External Signatory | 0 companies |
| Gunvor Maria Karlsson | Deputy Board Member | 0 companies |
| Åsa Maria Kristina Karlsson | Board of Directors | 0 companies |
| Elin Birgitta Jern Muzdalo | Chairman | 0 companies |